In conclusion, we clearly demonstrate that the initiation of insulin therapy is associated with an acute, but transient, rise in myocardial lipid content in patients with long standing type 2 diabetes and poor metabolic control. The gene discussed is INS; the disease is type 2 diabetes mellitus.